China News Service, February 9th. According to the "Central News Agency" report, the European Union began to implement control measures on the export of part of the new crown vaccine produced in the country at the end of January.
On February 9, local time, Japanese Minister of Administrative Reform Kono Taro confirmed that the European Union had approved the first batch of Pfizer Covid-19 vaccine exported to Japan, and that medical personnel would be given priority in vaccinating at that time.
Data map: On January 7, local time, in Tokyo, Japan, a passerby passed by an empty outdoor restaurant.
According to reports, Kono said that the EU has approved the first batch of Pfizer vaccines exported to Japan; as for the number of the first batch of vaccines, Kono did not disclose.
The Japanese government plans to vaccinate medical personnel from mid-February.
According to the report, the EU should approve each batch of vaccines exported to Japan.
Kono said that the vaccination schedule for all medical personnel and the elderly in Japan must be confirmed one by one in the future.
The EU approves the export of vaccines in batches, and Japan must also consider securing some stocks.
The European Union announced on January 29 that it has established a vaccine export transparency mechanism through an emergency authorization procedure, and will implement control over the export of some new crown vaccines produced in the EU.
The report pointed out that Pfizer in the United States, which has applied for vaccine approval from the Japanese government, has vaccine production bases in Belgium and Germany; AstraZeneca in the UK also has vaccine production bases in Belgium and the Netherlands.